In the article on page 40 of the January 2013 issue, two errors were noted by the authors that require correction. In the first, the authors noted during the page proof stage that the number of subjects randomized to placebo who underwent re-thoracotomy should have been reported as 4 rather than 1. They made this change in table 4 and in the text of the Safety section on page 46, but failed to change the sentence mentioning relative risk in the same paragraph. This should be 1.1, rather than 4.4. In the same section, the following information should have been presented: “In seven patients (four patients in the fibrinogen concentrate group and three patients in the placebo group), a surgical source of bleeding was identified during re-thoracotomy.” Consequently, the Discussion section should have also been modified on page 48, as follows: “Four patients in the fibrinogen concentrate group underwent re-thoracotomy, the same number as in the placebo group. Surgical bleeding was identified in almost all of these cases.”
The Journal notes with concern that the publisher effected changes to text and data, made by the authors during the article proofing stage after peer review, without notification of the Editorial Office. The publisher regrets failing to notify the Editorial Office of these changes before printing.
In addition, after publication, the authors note changes in cardiopulmonary bypass (CPB) times in table 1 and the row title for re-thoracotomy in table 4, as below.
